Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: NOVOTECH DRUG DEVELOPMENT CONSULTING LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-08-20 to 2022-08-19
Current total value of award: $45607.5
Description: EO14042 - REGULATORY SUPPORT FOR FDA IND APPLICATION: QGRFT FOR THE PREVENTION OF SARS-COV-2 INFECTION. THIS IS A COVID-19 REQUIREMENT.